Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

BCL2-Associated Athanogene 3 (BAG3) Peptide

BAG3 Reactivity: Human Host: Synthetic BP, BI
Catalog No. ABIN5686050
  • Target See all BAG3 products
    BAG3 (BCL2-Associated Athanogene 3 (BAG3))
    Origin
    Human
    Source
    • 7
    Synthetic
    Application
    Blocking Peptide (BP), BioImaging (BI)
    Characteristics
    BAG3 peptide corresponds to 12 amino acids of BAG3.
  • Application Notes
    BAG3 peptide is used for blocking the activity of BAG3 antibody . The BAG3 antibody ships at 0.5 mg/mL and the STK36 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide..
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    BAG3 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
    Storage
    -20 °C
    Storage Comment
    Store at -20°C. When reconstituted minimize freezing and thawing.
  • Target
    BAG3 (BCL2-Associated Athanogene 3 (BAG3))
    Gene ID
    9531
    NCBI Accession
    NP_004272
    OMIM
    14043024
    UniProt
    O95817
You are here:
Support